
N.C. A&T Researchers: Extracellular Vesicles May Change How We Treat Cancer, Neurological Disease
By Jamie Crockett / 03/14/2025 Research, Joint School of Nanoscience and Nanoengineering
- 4-H and Youth Development News
- Academic Affairs News
- Accounting and Finance News
- Administration and Instructional Services News
- Admissions News
- Agribusiness, Applied Economics and Agriscience Education News
- Agricultural and Natural Resources News
- All News
- Alumni News
- Animal Sciences News
- Applied Engineering Technology News
- Athletics News
- Biology News
- Built Environment News
- Business and Finance News
- Business Education News
- CAES News
- CAHSS News
- Chancellor's Speaker Series
- Chancellors Town Hall Series
- Chemical, Biological, and Bio Engineering News
- Chemistry News
- Civil, Architectural and Environmental Engineering News
- COE News
- COED News
- College News
- Community and Rural Development News
- Computational Science and Engineering News
- Computer Science News
- Computer Systems Technology News
- Cooperative Extension News
- COST News
- COST News
- Counseling News
- Criminal Justice News
- Deese College News
- Economics News
- Educator Preparation News
- Electrical and Computer Engineering News
- Employees News
- Energy and Environmental Systems News
- English Department News
- Family and Consumer Sciences News
- Graphic Design Technology News
- Hairston College News
- Headlines News
- History & Political Science News
- Honors College News
- Human Resources News
- Industrial and Systems Engineering News
- Information Technology Services News
- Innovation Station News
- Journalism & Mass Communication
- JSNN News
- Kinesiology News
- Leadership Studies and Adult Education News
- Liberal Studies News
- Library News
- Magazine News
- Management News
- Marketing News
- Mathematics News
- Mechanical Engineering News
- Media Spotlight News
- Natural Resources and Environmental Design News
- News Categories
- Nursing News
- Psychology News
- Research News
- Social Work News
- Strategic Partnerships and Economic Development News
- Student Affairs News
- Students News
- The Graduate College News
- Transportation & Supply Chain
- University Advancement News
- Visual & Performing Arts News
EAST GREENSBORO, N.C. (March 14, 2025) — Small, membrane-bound structures that cells in the human body release to transport a variety of proteins, nucleic acids and metabolites may also be used to carry specialized treatments for a wide array of diseases across a critical layer of cells meant to protect the brain against pathogens: the blood-brain barrier.
Writing in the peer-reviewed journal Advanced Biology, a team of nanoengineers from North Carolina Agricultural and Technical State University explored four categories of chronic illnesses and how the small structures, known as extracellular vesicles (EVs), can be utilized for both diagnosis and treatment: cancer, cardiovascular disease, orthopedic disease and neurological diseases, such as Alzheimer’s and Parkinson’s diseases.
Principal investigator Kristen Dellinger, Ph.D., an assistant professor of nanoengineering and founder of the Joint School of Nanoscience and Nanoengineering’s NanoBio Innovation Lab describes EVs as “tiny lipid packages” that can be used for intercellular communication and transportation. Because of their cellular characteristics, EVs are capable of carrying various therapies across biological barriers.
Dellinger and her team focused on EV’s potential to cross the blood-brain barrier and synthesized findings from nearly 250 reference sources for their comprehensive review. Doctoral students Farbod Ebrahimi, Anjali Kumari, Samaneh Ghadami and Saqer Al Abdullah contributed to “The Potential for Extracellular Vesicles in Nanomedicine: A Review of Recent Advancements and Challenges Ahead.”
A Subcategory of EVs: Exosomes
Exosomes are a subcategory of EVs that measure between 30 and 150 nanometers. A nanometer is 10-9 meters, making exosomes incredibly small — about 1,000 times smaller than the width of a human hair. Exosomes play a significant role in physiological and pathological processes.
Exosomes’ numerous benefits include their superior tissue penetration, efficient and consistent cellular internalization and more predictable biodistribution of whatever they are carrying. They are generally considered better alternatives to synthetic nanoparticles because they are naturally released from cells and so potentially less toxic to the body.
Exosomes have been considered a novel potential alternative to radiation therapy, chemotherapy and other cancer interventions because “the tissue selectivity, safety, crossing biological barriers and stability of exosomes make them advantageous as drug delivery systems” among other potential benefits, the research team wrote.
With regard to cardiovascular disease or CVD, toxicity and other challenges diminish synthetic nanocarriers’ efficacy as nanocarriers for drug carriers. Exosomes can “function as carriers of CVD-related active agents to target cells for their cardiac regenerative and protective potential,” the researchers explain in the article.
The team referenced previous research of a triple hybrid cellular nanovesicle design that showed promise in addressing cardiac injury, though there are still challenges to mitigate, which the NanoBio Innovation Lab is working on at A&T.
The team encouraged further research on those challenges, including a lack of standardized procedures in using exosomes and lack of established quality control, as well as studies that measure therapeutic effects and long-term safety of exosome-mediated treatment.
Dellinger’s team has secured substantial funding, including a two-year $369,024 NCInnovation grant for drug delivery research in 2024.
Media Contact Information: jicrockett@ncat.edu